HAIDEN EDORE: Open Payments
NPI 1306232491 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 27 payments from 9 companies in 2025. Trend: 2023 $467 · 2024 $576 · 2025 $446
Food & beverage: $442Education: $3
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $107 |
| ABBVIE INC. | 5 | $100 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| Amgen Inc. | 2 | $28 |
| PFIZER INC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
| Travere Therapeutics, Inc. | 2 | $3 |
Products named: IBSRELA, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, Wegovy, PREVNAR 20, SHINGRIX, OTEZLA.
Industry payments across GA — which companies pay providers there.
